BNT162b2 Vaccine 95 Percent Effective for Preventing COVID-19
Published data on Pfizer-BioNTech vaccine show similar efficacy across subgroups based on age, race, BMI, presence of coexisting conditions
70 Percent Efficacy Found for Oxford COVID-19 Vaccine
Acceptable safety profile identified, with three serious adverse events classified as possibly related to the vaccine
U.S. Marshals to Protect COVID-19 Vaccines
Deputies will be posted at stockpiles, manufacturers, transport areas, and receiving facilities
Essential Workers Have Increased Risk for Severe COVID-19
Highest risk for testing positive or death due to COVID-19 was seen for non-White essential workers
FDA Advisory Committee OKs Pfizer-BioNTech COVID-19 Vaccine
Committee recommends emergency use authorization of the vaccine; vaccine to be distributed within 24 hours of EUA
Glucosamine Supplement Tied to Lower Mortality
Regular use tied to a 65 percent reduced risk for cardiovascular death
Sildenafil, Trazodone Tablets Recalled After Being Packaged Together
AvKARE says it is not aware of any patients being harmed by the recalled products
FDA Authorizes First OTC COVID-19 Home Test Collection Kit
Last week, the agency also authorized an at-home test collection kit for COVID-19 and flu, available by prescription
Life Expectancy, Costs for RA Patients Examined
Lifetime expectancy after RA diagnosis found to be 26.3 years in patients diagnosed after 2003; lifetime cost estimated to be $72,953
ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL
Phase 2 study reveals high objective response rate for CAR T-cell therapy in patients with follicular lymphoma, marginal zone lymphoma
